-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Seoul, South Korea, October 21, 2021/PRNewswire/ - The Korean Ginseng Research Institute recently released a report on "Red Ginseng Vaccine Adjuvant Effect"[1] and "Respiratory Injury Prevention Effect" Summary of research results
Korean Ginseng Research Institute announces that red ginseng may have the adjuvant effect of new crown vaccine
The research results outlined in this review show that red ginseng improves the effectiveness of the vaccine.
In the paper "Protective Effect of Korean Red Ginseng Extract on the Infections by H1N1 and H3N2 Influenza Viruses in Mice" published in the international academic journal "Journal of Medicinal Food" in 2021, it is mentioned that compared with mice that were only vaccinated, vaccinated The survival rate of mice receiving the vaccine and taking red ginseng concentrate has improved
In the paper "Korean Red Ginseng enhances pneumococcal Δ pep27 vaccine efficacy by inhibiting reactive oxygen species production" published in the Journal of Ginseng Research in 2019, it was mentioned that mice infected with pneumococcal were injected with the vaccine (Δ pep27) at the same time.
According to the Korean Ginseng Research Institute, these findings prove the vaccine adjuvant effect of red ginseng and the preventive effect of respiratory damage
In South Korea, red ginseng has been officially recognized as a healthy functional food by the Ministry of Food and Drug Safety, a national agency that regulates drug and food safety
The representative red ginseng company in South Korea is the Korean Ginseng Corporation, whose famous CheongKwanJang brand accounts for about 70% of the entire red ginseng market
Last year, the Korean Ginseng Corporation and the International Vaccine Institute (IVI) signed a memorandum of understanding, and the two sides cooperated in the development of immune enhancers and the ingredients required for the use of red ginseng for new crown vaccine research
Immune enhancers are substances that enhance the immune response caused by antigens
Kim Jae-soo, president of the Korean Ginseng Corporation, said: “After the spread of the new crown virus, the number of people looking for red ginseng to improve immunity and manage health has increased significantly in South Korea
https://youtu.
[1].
KGC (Korea Ginseng Corp.